{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:12:41Z","timestamp":1761743561143},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.suronc.2011.10.004","type":"journal-article","created":{"date-parts":[[2011,11,18]],"date-time":"2011-11-18T15:05:31Z","timestamp":1321628731000},"page":"e17-e22","source":"Crossref","is-referenced-by-count":10,"title":["Selective organ preservation in muscle-invasive bladder cancer: Review of the literature"],"prefix":"10.1016","volume":"21","author":[{"given":"Parham","family":"Khosravi-Shahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Cabez\u00f3n-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"55","key":"10.1016\/j.suronc.2011.10.004_bib1","first-page":"74","article-title":"Global cancer statistics","volume":"2005","author":"Parkin","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.suronc.2011.10.004_bib2","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.suronc.2011.10.004_bib3","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3322\/caac.20006","article-title":"Cancer statistics, 2009","volume":"59","author":"Jemal","year":"2009","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.suronc.2011.10.004_bib4","series-title":"World Health Organization classification of tumors. Tumors of the urinary system and genital organs. Pathology and genetics","author":"Eble","year":"2004"},{"key":"10.1016\/j.suronc.2011.10.004_bib6","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM199311043291903","article-title":"Selective bladder preservation by combination treatment of invasive bladder cancer","volume":"329","author":"Kaufman","year":"1993","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.suronc.2011.10.004_bib7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0090-4295(02)01650-3","article-title":"Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer","volume":"60","author":"Shipley","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.suronc.2011.10.004_bib8","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1200\/JCO.2002.11.027","article-title":"Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results","volume":"20","author":"R\u00f6del","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suronc.2011.10.004_bib9","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1200\/JCO.1993.11.11.2150","article-title":"Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: a prospective study","volume":"11","author":"Housset","year":"1993","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suronc.2011.10.004_bib10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/0360-3016(93)90306-G","article-title":"Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12","volume":"25","author":"Tester","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.suronc.2011.10.004_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1200\/JCO.1996.14.1.119","article-title":"Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 88-02","volume":"14","author":"Tester","year":"1996","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suronc.2011.10.004_bib12","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1634\/theoncologist.5-6-471","volume":"5","author":"Kaufman","year":"2000","journal-title":"Oncologist"},{"key":"10.1016\/j.suronc.2011.10.004_bib13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0360-3016(03)00718-1","article-title":"RTOG 97-06: initial report of a phase I-II trial of selective bladder conservation using TURBT, twice-daily accelerated irradiation sensitized with cisplatin, and adjuvant MCV combination chemotherapy","volume":"57","author":"Hagan","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.suronc.2011.10.004_bib14","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1200\/JCO.1998.16.11.3576","article-title":"Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03","volume":"16","author":"Shipley","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suronc.2011.10.004_bib15","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/cncr.11232","article-title":"Can patient selection for bladder preservation be based on response to chemotherapy?","volume":"79","author":"Sternberg","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.suronc.2011.10.004_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1200\/JCO.2001.19.1.89","article-title":"Transurethral resection of muscle-invasive bladder cancer: 10-year outcome","volume":"19","author":"Herr","year":"2001","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.suronc.2011.10.004_bib17","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2007.08.007","article-title":"Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy","volume":"70","author":"Weiss","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.suronc.2011.10.004_bib18","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0090-4295(01)01219-5","article-title":"Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder","volume":"58","author":"Zietman","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.suronc.2011.10.004_bib19","first-page":"29","article-title":"Salvage radical cystoprostatectomy and orthotopic urinary diversion following radiation failure","volume":"160","author":"Bochner","year":"1998","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.suronc.2011.10.004_bib20","first-page":"1448","article-title":"Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: failure analysis","volume":"142","author":"Gospodarowicz","year":"1989","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.suronc.2011.10.004_bib21","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.urolonc.2006.09.015","article-title":"Long-term outcome of radiation-based conservation therapy for invasive bladder cancer","volume":"25","author":"Chung","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1016\/j.suronc.2011.10.004_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/cncr.23137","article-title":"Bladder-sparing, combined-modality approach for muscle-invasive bladder cancer: a multi-institutional, long-term experience","volume":"112","author":"Perdon\u00e0","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.suronc.2011.10.004_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0360-3016(94)E0135-7","article-title":"Analysis of failure following definitive radiotherapy for invasive transitional cell carcinoma of the bladder","volume":"31","author":"Mameghan","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.suronc.2011.10.004_bib24","article-title":"Concomitant fluorouracil (5-fu)\u2013cisplatin (cddp) and bifractionated split course radiation therapy (bscrt) for invasive bladder cancer","volume":"15","author":"Housset","year":"1997","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.suronc.2011.10.004_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ijrobp.2004.09.047","volume":"62","author":"Chakravarti","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.suronc.2011.10.004_bib26","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/bjc.1994.220","article-title":"Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis","volume":"69","author":"Lipponen","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.suronc.2011.10.004_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ncpuro0750","article-title":"Quality-of-life assessment in patients with bladder cancer","volume":"4","author":"Wright","year":"2007","journal-title":"Nat Clin Pract Urol"},{"key":"10.1016\/j.suronc.2011.10.004_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semradonc.2004.07.009","article-title":"The surgical management of muscle invasive bladder cancer: a contemporary review","volume":"15","author":"Cookson","year":"2005","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.suronc.2011.10.004_bib29","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0167-8140(01)00455-8","article-title":"Distressful symptoms after radical radiotherapy for urinary bladder cancer","volume":"62","author":"Henningsohn","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.suronc.2011.10.004_bib30","first-page":"1772","article-title":"Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors","volume":"170","author":"Zietman","year":"2003","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.suronc.2011.10.004_bib31","first-page":"1111","article-title":"Cystectomy for bladder cancer: a contemporary series","volume":"165","author":"Dalbagni","year":"2001","journal-title":"J\u00a0Urol"}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740411000880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740411000880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T05:56:14Z","timestamp":1543384574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740411000880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0960740411000880"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2011.10.004","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}